These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28076829)

  • 1. Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
    Sayyah-Melli M; Mobasseri M; Gharabaghi PM; Ouladsahebmadarek E; Rahmani V
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():257-264. PubMed ID: 28076829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effects of cabergoline (Dostinex) on women with symptomatic myomatous uterus: a randomized trial.
    Vahdat M; Kashanian M; Ghaziani N; Sheikhansari N
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():74-78. PubMed ID: 27639604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
    Duhan N; Madaan S; Sen J
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
    Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors for uterine fibroids.
    Song H; Lu D; Navaratnam K; Shi G
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009505. PubMed ID: 24151065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
    Leone Roberti Maggiore U; Scala C; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():157-62. PubMed ID: 25150954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of symptomatic uterine leiomyoma with letrozole.
    Gurates B; Parmaksiz C; Kilic G; Celik H; Kumru S; Simsek M
    Reprod Biomed Online; 2008 Oct; 17(4):569-74. PubMed ID: 18854113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes.
    Sayyah-Melli M; Tehrani-Gadim S; Dastranj-Tabrizi A; Gatrehsamani F; Morteza G; Ouladesahebmadarek E; Farzadi L; Kazemi-Shishvan M
    Saudi Med J; 2009 Aug; 30(8):1024-33. PubMed ID: 19668882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letrozole monotherapy in the treatment of uterine myomas.
    Ferrero S; Venturini PL; Remorgida V
    Fertil Steril; 2010 May; 93(7):e31; author reply e32. PubMed ID: 20356584
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression.
    Melli MS; Farzadi L; Madarek EO
    Saudi Med J; 2007 Mar; 28(3):445-50. PubMed ID: 17334477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
    George S; Feng Y; Manola J; Nucci MR; Butrynski JE; Morgan JA; Ramaiya N; Quek R; Penson RT; Wagner AJ; Harmon D; Demetri GD; Krasner C
    Cancer; 2014 Mar; 120(5):738-43. PubMed ID: 24222211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.
    Şahin N; Apaydın N; Töz E; Sivrikoz ON; Genç M; Turan GA; Cengiz H; Eskicioğlu F
    Arch Gynecol Obstet; 2016 May; 293(5):1101-6. PubMed ID: 26690356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.
    Lu C; Lee HS; Pappas GP; Dilling DF; Burger CD; Shifren A; Veeraraghavan S; Chapman JT; Parambil J; Ruoss SJ; Young LR; Hammes SR; Kopras EJ; Roads T; Krischer JP; McCormack FX;
    Ann Am Thorac Soc; 2017 Jun; 14(6):919-928. PubMed ID: 28570161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
    Hilário SG; Bozzini N; Borsari R; Baracat EC
    Fertil Steril; 2009 Jan; 91(1):240-3. PubMed ID: 18249392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
    Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
    Fedele L; Bianchi S; Raffaelli R; Zanconato G
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):91-4. PubMed ID: 10659924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.
    Azmoodeh A; Pejman Manesh M; Akbari Asbagh F; Ghaseminejad A; Hamzehgardeshi Z
    Glob J Health Sci; 2015 Sep; 8(4):244-52. PubMed ID: 26573024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.
    Dowsett M; Pfister C; Johnston SR; Miles DW; Houston SJ; Verbeek JA; Gundacker H; Sioufi A; Smith IE
    Clin Cancer Res; 1999 Sep; 5(9):2338-43. PubMed ID: 10499602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.